サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1777370

血管内カテーテルの世界市場

Intravascular Catheters

出版日
ページ情報
英文 384 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
血管内カテーテルの世界市場
出版日: 2025年07月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 384 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血管内カテーテルの世界市場は2030年までに151億米ドルに到達

2024年に76億米ドルと推定される血管内カテーテルの世界市場は、2024年から2030年にかけてCAGR 12.0％で成長し、2030年には151億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるショートPIVCは、CAGR13.4％を記録し、分析期間終了時には109億米ドルに達すると予測されます。統合型/閉鎖型PIVCセグメントの成長率は、分析期間中CAGR 8.9%と推定されます。

米国市場は21億米ドル、中国はCAGR16.4％で成長予測

米国の血管内カテーテル市場は、2024年には21億米ドルになると推定されます。世界第2位の経済大国である中国は、2030年までに32億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは16.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.6%と10.8%と予測されています。欧州では、ドイツがCAGR約9.5%で成長すると予測されています。

世界の血管内カテーテル市場- 主要動向と促進要因のまとめ

血管内カテーテルは医療手順にどのような革命をもたらすか？

血管内カテーテル市場は、低侵襲処置の需要の増加、カテーテル技術の進歩、バスキュラーアクセスを必要とする慢性疾患の有病率の上昇により、大きな成長を遂げています。血管内カテーテルは、薬剤投与、輸液、血液透析、心血管インターベンション、重症患者モニタリングなど、幅広い医療用途に不可欠です。これらのカテーテルは、安全で効率的かつ正確な血管へのアクセスを提供し、従来の外科的介入に伴う合併症を軽減します。

心血管疾患（CVD）、がん治療、透析を必要とする末期腎不全（ESRD）の世界の増加に伴い、血管内カテーテルの採用は病院、外来手術センター、在宅医療の現場で増加しています。さらに、インターベンショナル心臓病学、神経学、放射線学の成長により、血管形成術、ステント留置術、血栓除去術などの精密な手技を行うための特殊なガイディングカテーテル、バルーンカテーテル、マイクロカテーテルの使用が拡大しています。

抗菌コートカテーテル、生体吸収性カテーテル、カテーテルナビゲーションシステムなどの技術的進歩により、感染管理、患者の安全性、手技の効率性が向上しています。低侵襲治療へのシフトは、外来患者におけるカテーテルを用いた治療の使用増加と相まって、継続的な市場拡大の原動力になると予想されます。

血管内カテーテル市場を形成する主要動向は？

血管内カテーテル市場で最も注目すべき動向の1つは、抗菌剤およびヘパリンコートカテーテルの開発です。カテーテル関連血流感染（CLABSI）や血栓症は、カテーテルの長期使用における主要な合併症であり、入院や死亡率の上昇につながります。これに対処するため、メーカーは銀イオン、クロルヘキシジン、抗菌コーティングを組み込んだカテーテルを導入し、感染リスクの低減とカテーテルの長寿命化を図っています。

もう1つの主要動向は、カテーテルにスマートセンサーとリアルタイムモニタリング機能を統合することです。圧力センサー、ワイヤレス接続、マイクロ流体技術を搭載したスマートカテーテルは、連続的な血行動態モニタリング、閉塞の早期発見、輸液管理の改善を可能にしています。これらの技術革新は、特に集中治療室（ICU）やインターベンショナル・カーディオロジーにおいて、リアルタイムの患者データによって転帰を大幅に改善できる貴重なものです。

末梢挿入型中心静脈カテーテル（PICC）と正中線カテーテルの採用が増加していることも、市場を再形成しています。PICCは中心静脈カテーテル（CVC）に代わる長期静脈療法用カテーテルで、静脈穿刺を繰り返す必要性を減らします。中間的なバスキュラーアクセスを提供するミッドラインカテーテルは、外来患者や在宅ヘルスケアで普及しつつあり、中心静脈ライン感染に関連するリスクを伴わずに、費用対効果の高い長期静脈内治療を可能にしています。

もうひとつの新たな動向は、生分解性および生体吸収性カテーテルの使用です。従来のポリマーベースのカテーテルは異物反応や血栓症を引き起こす可能性があるのに対し、生分解性カテーテルは時間の経過とともに溶解するため、長期的な合併症を最小限に抑えることができます。この技術革新は、一時的なカテーテル留置、神経血管インターベンション、小児用途など、残留異物を最小限に抑えることが重要な場合に特に有益です。

さらに、インターベンションや診断カテーテル治療の増加が、マイクロカテーテルやステアラブル・ガイディング・カテーテルの需要を牽引しています。これらの特殊器具は、血管形成術、塞栓術、神経インターベンション、電気生理学的処置に広く使用され、複雑な血管構造を通して正確なナビゲーションを可能にします。ロボット支援型カテーテルナビゲーションシステムの採用が増加しており、カテーテルを用いたインターベンションの精度、効率、手技の成功率がさらに向上しています。

血管内カテーテル市場に影響を与えている課題は？

血管内カテーテル技術の数々の進歩にもかかわらず、いくつかの課題が普及と市場成長の妨げとなっています。主な懸念事項の1つはカテーテルに関連した感染症や血栓症で、深刻な合併症や入院期間の延長、ヘルスケアコストの増加につながる可能性があります。抗菌コーティングや最先端のカテーテル素材は感染リスクの低減に役立つが、合併症の予防には厳格な無菌手技と定期的なカテーテル・メンテナンスが不可欠です。

もう1つの大きな課題は、高度なカテーテル治療器具や手技のコストが高いことです。薬剤溶出性カテーテル、生体吸収性カテーテル、センサー一体型カテーテルは高価であるため、低所得地域では利用しにくいです。さらに、特定の国では、カテーテルを用いた高度な治療に対する償還が制限されているため、患者が最先端の治療にアクセスすることが制限される可能性があります。

規制上のハードルや厳しい承認プロセスも、市場参入者にとっての課題です。FDA（米国食品医薬品局）、EMA（欧州医薬品庁）、PMDA（医薬品医療機器総合機構）などの医療機器規制当局は、新しいカテーテル技術、コーティング、材料に対して厳しい臨床試験要件を課しています。時間のかかる承認プロセスは製品の上市を遅らせ、開発コストを増大させる。

材料の生体適合性とカテーテルの耐久性も重要な懸念事項です。シリコーン、ポリウレタン、PTFE（ポリテトラフルオロエチレン）製のカテーテルは、血栓形成や血管外傷を防ぐため、最適な柔軟性、耐キンク性、血行力学的安定性を示さなければならないです。低い血栓形成性を確保しつつ、柔らかさと耐久性のバランスをとることは、製造業者にとって依然として技術的課題です。

さらに、高度なカテーテル治療の訓練を受けた熟練したヘルスケア専門家の不足が、地域によっては制限要因となっています。インターベンショナル・カーディオロジスト、放射線科医、血管外科医が複雑なカテーテルインターベンションを扱うには専門的なトレーニングが必要であり、専門知識の不足は手技の成功率に影響を与えかねないです。

血管内カテーテル市場の成長を促進する要因とは？

血管内カテーテル市場の成長は、心血管疾患の罹患率の上昇、低侵襲インターベンションの増加、カテーテル技術の継続的な革新など、いくつかの要因によってもたらされます。主要な促進要因の1つは、冠動脈疾患（CAD）、脳卒中、末梢動脈疾患（PAD）などの心血管疾患の有病率の増加であり、これらの疾患には血管形成術、ステント留置術、血栓除去術などのカテーテルを用いた介入が必要です。

もう1つの重要な推進力は、腫瘍学、腎臓学、神経学におけるカテーテルの用途拡大です。カテーテルを用いた化学療法の注入、末期腎不全（ESRD）用の透析カテーテル、脳卒中治療用の神経血管カテーテルなどが市場の成長に寄与しています。がんや腎臓病の世界の負担増が、長期的なバスキュラーアクセスデバイスの需要を促進しています。

外来や在宅での輸液療法の採用が増加していることも、市場拡大にさらに拍車をかけています。末梢挿入型中心静脈カテーテル（PICC）や正中線カテーテルは、長期的な抗生物質療法、化学療法、非経口栄養療法に広く使用されており、患者は病院の外で治療を受けることができます。この動向は、慢性疾患の管理や高齢者医療において特に重要であり、在宅での静脈内治療により入院やヘルスケアコストが削減されます。

ロボット支援カテーテルナビゲーション、リアルタイム圧力感知カテーテル、3D画像支援カテーテル留置などの技術的進歩は、低侵襲血管処置の精度と安全性を高めています。AIを活用したカテーテル留置ガイダンスシステムの導入は、合併症の減少、手技結果の改善、手技時間の短縮に役立っています。

さらに、血管アクセスケアとカテーテルベースの治療インフラを改善するための政府の取り組みやヘルスケアへの投資が、市場の成長を支えています。多くの新興諸国がインターベンショナル・カーディオロジーや透析センターを拡張しており、高品質のバスキュラー・アクセス・ソリューションの採用を増やしています。

カテーテルコーティング、生分解性材料、スマートセンサー、AI主導型画像処理などの進歩が続いていることから、血管内カテーテル市場は継続的な成長と革新が見込まれています。感染対策、費用対効果の高いソリューション、規制遵守に注力する企業は、世界中のヘルスケアプロバイダーと患者の進化するニーズを満たす上で競争上の優位性を獲得すると思われます。

セグメント

製品（ショートPIVC、統合/クローズドPIVC）、用途（腫瘍学、消化器病学、腎臓病学、感染症学、その他）、最終用途（病院、診療所、外来手術センター、在宅医療、その他）

調査対象企業の例

  • AMECATH
  • AngioDynamics, Inc.
  • Angiplast Pvt. Ltd.
  • Argon Medical Devices, Inc.
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company（BD）
  • Boston Scientific Corporation
  • Cook Medical
  • Edwards Lifesciences Corporation
  • Hindustan Syringes & Medical Devices Ltd.
  • ICU Medical, Inc.
  • Johnson & Johnson
  • McKesson Corporation
  • Medline Industries, Inc.
  • Medtronic PLC
  • Nipro Medical Corporation
  • PRODiMED
  • Romsons Scientific & Surgical Pvt. Ltd.
  • Smiths Medical

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP31676

Global Intravascular Catheters Market to Reach US$15.1 Billion by 2030

The global market for Intravascular Catheters estimated at US$7.6 Billion in the year 2024, is expected to reach US$15.1 Billion by 2030, growing at a CAGR of 12.0% over the analysis period 2024-2030. Short PIVC, one of the segments analyzed in the report, is expected to record a 13.4% CAGR and reach US$10.9 Billion by the end of the analysis period. Growth in the Integrated / Closed PIVC segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 16.4% CAGR

The Intravascular Catheters market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 16.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.6% and 10.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Intravascular Catheters Market - Key Trends & Drivers Summarized

How Are Intravascular Catheters Revolutionizing Medical Procedures?

The intravascular catheters market is witnessing significant growth due to increasing demand for minimally invasive procedures, advancements in catheter technology, and rising prevalence of chronic diseases requiring vascular access. Intravascular catheters are essential for a wide range of medical applications, including drug administration, fluid infusion, hemodialysis, cardiovascular interventions, and critical care monitoring. These catheters provide safe, efficient, and precise access to blood vessels, reducing complications associated with traditional surgical interventions.

With the global rise in cardiovascular diseases (CVDs), cancer treatments, and end-stage renal disease (ESRD) requiring dialysis, intravascular catheter adoption is increasing across hospitals, ambulatory surgical centers, and home healthcare settings. Additionally, the growth of interventional cardiology, neurology, and radiology has expanded the use of specialized guiding catheters, balloon catheters, and microcatheters for precision-based procedures such as angioplasty, stent placement, and thrombectomy.

Technological advancements, such as antimicrobial-coated catheters, bioabsorbable catheters, and catheter navigation systems, are enhancing infection control, patient safety, and procedural efficiency. The shift toward minimally invasive treatments, coupled with the increasing use of catheter-based therapies in outpatient settings, is expected to drive continued market expansion.

What Are the Key Trends Shaping the Intravascular Catheters Market?

One of the most notable trends in the intravascular catheters market is the development of antimicrobial and heparin-coated catheters. Catheter-associated bloodstream infections (CLABSIs) and thrombosis are major complications in long-term catheter use, leading to increased hospitalizations and mortality rates. To address this, manufacturers are introducing catheters embedded with silver-ion, chlorhexidine, and antimicrobial coatings to reduce infection risks and improve catheter longevity.

Another key trend is the integration of smart sensors and real-time monitoring capabilities in catheters. Smart catheters equipped with pressure sensors, wireless connectivity, and microfluidic technology are enabling continuous hemodynamic monitoring, early detection of blockages, and improved fluid management. These innovations are particularly valuable in intensive care units (ICUs) and interventional cardiology, where real-time patient data can significantly improve outcomes.

The increasing adoption of peripherally inserted central catheters (PICCs) and midline catheters is also reshaping the market. PICCs offer an alternative to central venous catheters (CVCs) for long-term intravenous therapy, reducing the need for repeated venipunctures. Midline catheters, which provide intermediate vascular access, are gaining traction in outpatient settings and home healthcare, enabling cost-effective, extended IV therapy without the risks associated with central line infections.

Another emerging trend is the use of biodegradable and bioresorbable catheters. Traditional polymer-based catheters can cause foreign body reactions and thrombosis, whereas biodegradable catheters dissolve over time, minimizing long-term complications. This innovation is particularly beneficial in temporary catheter placements, neurovascular interventions, and pediatric applications where minimizing residual foreign material is critical.

Additionally, the rise in interventional and diagnostic catheterization procedures is driving demand for microcatheters and steerable guiding catheters. These specialized devices are widely used in angioplasty, embolization, neurointerventions, and electrophysiology procedures, allowing precise navigation through complex vascular structures. The increasing adoption of robot-assisted catheter navigation systems is further enhancing accuracy, efficiency, and procedural success rates in catheter-based interventions.

What Challenges Are Impacting the Intravascular Catheters Market?

Despite the numerous advancements in intravascular catheter technology, several challenges hinder widespread adoption and market growth. One of the primary concerns is catheter-related infections and thrombosis, which can lead to serious complications, extended hospital stays, and increased healthcare costs. While antimicrobial coatings and advanced catheter materials help reduce infection risks, strict aseptic techniques and regular catheter maintenance are essential to prevent complications.

Another major challenge is the high cost of advanced catheterization devices and procedures. Drug-eluting catheters, bioresorbable catheters, and sensor-integrated catheters come at a premium cost, making them less accessible in low-income regions. Additionally, reimbursement limitations for advanced catheter-based procedures in certain countries can restrict patient access to cutting-edge treatments.

Regulatory hurdles and stringent approval processes pose another challenge for market players. Medical device regulatory authorities such as the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and PMDA (Pharmaceuticals and Medical Devices Agency, Japan) impose strict clinical trial requirements for new catheter technologies, coatings, and materials. The time-consuming approval process can delay product launches and increase development costs.

Material biocompatibility and catheter durability are also key concerns. Catheters made from silicone, polyurethane, and PTFE (polytetrafluoroethylene) must exhibit optimal flexibility, kink resistance, and hemodynamic stability to prevent clot formation and vessel trauma. Balancing softness with durability while ensuring low thrombogenicity remains a technical challenge for manufacturers.

Additionally, the shortage of skilled healthcare professionals trained in advanced catheterization procedures is a limiting factor in some regions. Interventional cardiologists, radiologists, and vascular surgeons require specialized training to handle complex catheter-based interventions, and the lack of expertise can impact procedural success rates.

What Factors Are Driving the Growth of the Intravascular Catheters Market?

The growth in the intravascular catheters market is driven by several factors, including the rising incidence of cardiovascular diseases, the increasing use of minimally invasive interventions, and continuous innovations in catheter technology. One of the major drivers is the growing prevalence of cardiovascular disorders, such as coronary artery disease (CAD), stroke, and peripheral artery disease (PAD), which require catheter-based interventions such as angioplasty, stenting, and thrombectomy.

Another key driver is the expanding applications of catheters in oncology, nephrology, and neurology. Catheter-based chemotherapy infusion, dialysis catheters for end-stage renal disease (ESRD), and neurovascular catheters for stroke treatment are contributing to market growth. The rising global burden of cancer and kidney diseases is driving demand for long-term vascular access devices.

The increasing adoption of outpatient and home-based infusion therapies is further fueling market expansion. Peripherally inserted central catheters (PICCs) and midline catheters are being widely used for long-term antibiotic therapy, chemotherapy, and parenteral nutrition, allowing patients to receive treatment outside of hospital settings. This trend is particularly significant in chronic disease management and elderly patient care, where home-based IV therapy reduces hospital admissions and healthcare costs.

Technological advancements, such as robotic-assisted catheter navigation, real-time pressure-sensing catheters, and 3D imaging-assisted catheter placement, are enhancing the precision and safety of minimally invasive vascular procedures. The introduction of AI-driven catheter placement guidance systems is helping reduce complications, improve procedural outcomes, and shorten procedure times.

Additionally, government initiatives and healthcare investments in improving vascular access care and catheter-based treatment infrastructure are supporting market growth. Many developing countries are expanding interventional cardiology and dialysis centers, increasing the adoption of high-quality intravascular catheters and vascular access solutions.

With ongoing advancements in catheter coatings, biodegradable materials, smart sensors, and AI-driven imaging, the intravascular catheters market is poised for continuous growth and innovation. Companies that focus on infection control, cost-effective solutions, and regulatory compliance will gain a competitive advantage in meeting the evolving needs of healthcare providers and patients worldwide.

SCOPE OF STUDY:

The report analyzes the Intravascular Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Short PIVC, Integrated / Closed PIVC); Application (Oncology, Gastroenterology, Renal Disease, Infectious Diseases, Others); End-Use (Hospitals, Clinics, Ambulatory Surgery Centers, Homecare, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AMECATH
  • AngioDynamics, Inc.
  • Angiplast Pvt. Ltd.
  • Argon Medical Devices, Inc.
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company (BD)
  • Boston Scientific Corporation
  • Cook Medical
  • Edwards Lifesciences Corporation
  • Hindustan Syringes & Medical Devices Ltd.
  • ICU Medical, Inc.
  • Johnson & Johnson
  • McKesson Corporation
  • Medline Industries, Inc.
  • Medtronic PLC
  • Nipro Medical Corporation
  • PRODiMED
  • Romsons Scientific & Surgical Pvt. Ltd.
  • Smiths Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Intravascular Catheters - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Number of Hospital Admissions and ICU Stays Drives Demand for Intravascular Catheters
    • Growth in Chronic Disease Management and Long-Term Infusions Expands Market Scope
    • Increase in Chemotherapy and Parenteral Nutrition Applications Spurs Central Venous Catheter Use
    • Advancements in Catheter Materials and Antimicrobial Coatings Reduce Infection Risks and Improve Outcomes
    • Adoption of Ultrasound-Guided Insertion Techniques Strengthens Procedural Safety and Precision
    • Rising Use of Midline and PICC Catheters in Outpatient and Home Infusion Settings Enhances Access
    • Expansion of Interventional Radiology and Cardiology Procedures Fuels Specialized Catheter Demand
    • Integration With Electronic Monitoring Systems Enables Real-Time Flow and Pressure Measurement
    • Surge in Sepsis and Critical Care Cases Highlights Importance of Reliable Vascular Access
    • AI-Based Vascular Access Planning and Patient Stratification Tools Improve Catheter Placement Strategies
    • Growing Preference for Single-Use, Sterile Devices Boosts Disposable Catheter Sales
    • Increased Demand for Short Peripheral Catheters in Emergency and Ambulatory Care Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intravascular Catheters Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intravascular Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Short PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Short PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Short PIVC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Integrated / Closed PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Integrated / Closed PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Integrated / Closed PIVC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Homecare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Renal Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Renal Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Renal Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Intravascular Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Intravascular Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Intravascular Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Intravascular Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION